Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Clinical research Stories

2014-03-31 23:32:30

Combined companies provide unrivalled capabilities for adaptive and medical device trials worldwide. Reston, Virginia (PRWEB) March 31, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the design and implementation of innovative approaches that improve data quality, efficiency, and productivity of product development today announced that it has agreed, subject to certain closing conditions, to be acquired by ICON plc, (NASDAQ: ICLR),...

2014-03-31 20:22:33

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5q5tcr/global_orphan) has announced the addition of the "Concise Analysis of the International Orphan Drug Market Outlook 2018" [http://www.researchandmarkets.com/research/5q5tcr/global_orphan ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global pharmaceutical industry has been experiencing a slow growth in recent...

2014-03-31 16:27:39

LA JOLLA, Calif., March 31, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced that the Company was added to the Russell 2000® Index (as well as the larger Russell 3000® Index) at the close of market on March 31, 2014 as part of the quarterly Initial Public Offering (IPO) update to the Russell indexes. The...

2014-03-31 16:27:30

HAYWARD, Calif., March 31, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced the appointment of Steven Engle to and the departure of Dr. James Healy, MD, PhD from its Board of Directors. "Steve's extensive experience in late-stage clinical development will be an invaluable resource to the Company," said Dr. Christopher S. Henney, Chairman of...

2014-03-31 16:26:42

BOSTON, March 31, 2014 /PRNewswire/ -- About six months ago, the United States Food and Drug Administration (FDA) released new rules which require most medical devices distributed in the United States to bear a Unique Device Identification, or a UDI. Debara Reese, Vice President, Quality and Compliance, for global life sciences compliance consulting firm, Maetrics, recently spoke at the BioMed Conference in Boston where she explained, "The most common pitfall I've seen regarding UDI...

2014-03-31 08:29:05

MELBOURNE, Australia, March 31, 2014 /PRNewswire/ -- Prana Biotechnology (ASX:PBT/NASDAQ:PRAN) has today released the top line results of the 12-month Phase II Imaging trial in Alzheimer's Disease ("IMAGINE" Trial), based on draft results. Prana's PBT2 did not meet its primary endpoint of a statistically significant reduction in the levels of beta-amyloid plaques in the brains of prodromal/mild Alzheimer's disease patients, as measured using PiB-PET Standardized Uptake Value...

2014-03-31 08:28:28

More than half of biopharmaceutical companies surveyed use a Strategic Partnership model BOSTON, March 31, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today released Strategic Partnerships 2014: Driving Biopharmaceutical Outsourcing Effectiveness, at the 23rd Annual Partnerships in Clinical Trials Conference in Las Vegas, NV. It provides compelling insights that highlight the value of these multi-year, highly integrated...

2014-03-30 23:02:22

The Firm is actively evaluating GranuFlo recall lawsuits on behalf of individuals who allegedly suffered the deadly heart events associated with GranuFlo and NaturaLyte. New York, NY (PRWEB) March 30, 2014 Dialysis patients and families who may have been affected by the GranuFlo recall (http://www.thegranuflolawsuit.com/) are steadily filing claims in Massachusetts federal court over two medications allegedly tied to sudden cardiac death, heart attacks, strokes and other serious...

2014-03-28 23:25:53

Verified Clinical Trials is proud to announce their presence at the Partnerships In Clinical Trials meeting in Las Vegas, Nevada to discuss the largest North American clinical research volunteer database that stops dual enrollment in clinical trials, while promoting patient safety and data quality. VCT is partnered with the world's largest pharmaceutical companies and CROs and continues to grow at an exponential pace in an effort to eliminate the professional research subject. Garden...

2014-03-28 23:24:53

The Device Software Verification and Validation webinar rebroadcast will give attendees a clear understanding of FDA inspector expectations and how to meet them, with a specific focus on software that is as-product, in-product, process and/or in overall manufacturing and operations. Why risk FDA sanctions, let alone multimillion-dollar liability lawsuits? Falls Church, VA (PRWEB) March 28, 2014 Device Software Verification and Validation: Get Ready for a New Breed of Investigators...